Topical henna for capecitabine induced hand-foot syndrome

被引：36

作者：

Yucel, Idris ^{[1
]}

Guzin, Gonullu ^{[1
]}

机构：

[1] Ondokuz Mayis Univ, Sch Med, Dept Med Oncol, TR-55139 Kurupelit, Turkey

来源：

INVESTIGATIONAL NEW DRUGS | 2008年 / 26卷 / 02期

关键词：

henna; capecitabine; hand-foot;

D O I：

10.1007/s10637-007-9082-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Capecitabine is a chemotherapeutic drug for use in cancers. Hand-foot syndrome (HFS) is side effect of capecitabine which can lead the cessation of the therapy or dose reduction. Henna (Lawsonia inermis) is a traditionally used plant of Middle-East that is applied on hands and feet. Some of cancer patients in capecitabine treatment who developed HFS, we recommended to apply henna. In these patients, six patients were grade 3 HFS and four were grade 2 HFS. Complete response (CR) were seen in four of grade 3 HFS and all of grade 2; two grade 3 HFS improved to grade 1. So far, in the chemotherapy, there was no need of dose reduction and also no side effect of henna seen. Clinical improvement in these patients may relate to anti-inflammatory, antipyretic and analgesic effects of henna. Prospective studies are needed to show this therapeutic effect of henna.

引用

页码：189 / 192

页数：4

共 50 条

[21] Capecitabine-induced oral mucosal hyperpigmentation associated with hand-foot syndrome -- A literature review
do Nascimento, Anna Danielly Almeida
Porto, Debora Maria
Vidal, Aurora Karla de Lacerda
ANAIS BRASILEIROS DE DERMATOLOGIA, 2023, 98 (03) : 302 - 309
[22] Discoloration and Dilemma: A Case Report of Hand-Foot Syndrome Associated With Capecitabine Use
Gohil, Rucha
Bojanapati, Kalyan
Reddy, Keerthi
Kumar, Kavin
Kumar, J.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
[23] Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer
Dong, Si-Qi
Wang, Tong-Min
Zhang, Jiang-Bo
He, Yong-Qiao
Xue, Wen-Qiong
Wu, Zi-Yi
Yang, Da-Wei
Cao, Lian-Jing
Huang, Jing-Wen
Li, Xi-Zhao
Zhang, Pei-Fen
Zheng, Xiao-Hui
Jia, Wei-Hua
CANCER RESEARCH AND TREATMENT, 2021, 53 (03): : 724 - 732
[24] Hand-foot syndrome with sclerodactyly-like changes in a patient treated with capecitabine
Trindade, Felicidade
Haro, Rosario
Farina, Maria Carmen
Requena, Luis
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2008, 30 (02) : 172 - 173
[25] Predictive factors for the development of capecitabine-induced hand-foot syndrome: a retrospective observational cohort study
Chantharakhit, Chaichana
Sujaritvanichpong, Nantapa
ANNALS OF MEDICINE AND SURGERY, 2024, 86 (01): : 73 - 77
[26] Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy
Heo, YS
Chang, HM
Kim, TW
Ryu, MH
Ahn, JH
Kim, SB
Lee, JS
Kim, WK
Cho, HK
Kang, YK
JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10) : 1166 - 1172
[27] Evaluation of hand-foot syndrome and hand-foot skin reaction: Case series
Demirdag, Hatice Gamze
Ayanoglu, Burcu Tugrul
Armagan, Basak Yalici
TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2019, 53 (01): : 28 - 31
[28] Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
Elyasi, Sepideh
Shojaee, Farzaneh Sadat Rezazadeh
Allahyari, Abolghasem
Karimi, Gholamreza
PHYTOTHERAPY RESEARCH, 2017, 31 (09) : 1323 - 1329
[29] Randomized controlled trial on the efficacy of topical urea-based cream in preventing capecitabine-associated hand-foot syndrome
Wongkraisri, Concord
Chusuwanrak, Kriengkrai
Laocharoenkeat, Apirom
Chularojanamontri, Leena
Nimmannit, Akarin
Ithimakin, Suthinee
BMC CANCER, 2025, 25 (01)
[30] Prophylactic pyridoxine was not able to reduce the incidence of capecitabine-induced hand-foot syndrome: A meta-analysis
Zhou, Yun
Peng, Ling
Li, Yingjie
Chen, Lixun
BIOMEDICAL REPORTS, 2013, 1 (06) : 873 - 878

← 1 2 3 4 5 →